As medical professionals, we've seen it all when it comes to skin infections. However, the dreaded larva migrans is one that often leaves both patients and practitioners scratching their heads. This common yet perplexing condition can be frustrating to diagnose and treat, but fear not - in this post we'll dive into everything you need to know about larva migrans. From its causes and symptoms to effective treatment options, by the end of this article you'll have a better understanding of how to tackle this pesky infection head-on. So let's get started!
Larva migrans is a condition caused by the migration of parasitic larvae through the body. The most common type of larva migrans is cutaneous larva migrans (CLM), which results in a rash on the skin. Other types of larva migrans can affect the eyes, lungs, and brain. CLM is most often caused by the hookworm Ancylostoma braziliense. The larvae of this worm are typically found in warm, moist soil in tropical and subtropical regions. They can enter the body through the skin, typically when someone walks barefoot on contaminated ground. The larvae then migrate through the body, causing an itchy rash as they go. In some cases, the larvae may penetrate deeper tissues, leading to more serious problems such as eye or brain infections. CLM is usually treated with anti-parasitic medications. These drugs kill the migrating larvae and relieve symptoms within a few days. In some cases, however, CLM may cause permanent damage to the skin or other tissues. For this reason, it is important to seek medical treatment as soon as possible after exposure to contaminated soil.
There are two types of larva migrans: visceral and cutaneous. Visceral larva migrans (VLM) is the more serious form of the infection, and occurs when the larvae of certain types of worms invade and migrate through the body's organs, including the liver, lungs, and brain. This can lead to a wide range of symptoms, including fever, abdominal pain, coughing, and seizures. Cutaneous larva migrans (CLM), on the other hand, is a less serious form of the infection that occurs when the larvae of certain types of worms invade and migrate through the skin. This can cause an itchy rash or bumps on the skin.
Larva migrans is a common skin infection caused by parasitic nematode worms. The most common symptom of larva migrans is a linear, raised rash that follows the path of the worm as it migrates through the skin. Other symptoms may include itching, redness, and swelling. In severe cases, the rash may blister or ulcerate. If the worm enters the eye, it can cause vision problems.
Larva migrans is a common skin infection that can be caused by several different species of parasites, with differing levels of severity. It is important for medical professionals to understand the symptoms, diagnosis and treatment options available in order to provide proper care and advice to their patients. By following these guidelines, they can help ensure that their patients receive the best possible outcome from this often painful skin condition.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
3.
Using MRD Status to Deescalate Multiple Myeloma Therapy
4.
Kidney cancer: Understanding what a renal cell carcinoma diagnosis means
5.
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
1.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
2.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
3.
Exploring the Latest Advances in PTLD Cancer Treatment
4.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
5.
Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Oropharyngeal Cancer in Relation to HPV Status
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation